Global gene expression profiling in human lung cells exposed to cobalt

Area of Science:

• Toxicogenomics
• Occupational Health
• Pulmonary Toxicology

Background:

• Over 1 million US workers face occupational cobalt (Co) exposure, primarily via inhalation, leading to lung diseases.
• Cobalt is a possible human carcinogen (IARC Group 2B), but its lung toxicity mechanisms remain unclear.
• Understanding cobalt's cellular effects is crucial for risk assessment and developing preventative strategies.

Purpose of the Study:

• To identify gene expression signatures of acute cobalt (Co) exposure using a toxicogenomic approach.
• To investigate cellular processes and protein targets relevant to cobalt carcinogenesis, transport, and biomarker discovery.
• To elucidate the molecular mechanisms underlying cobalt-induced lung toxicity.

Main Methods:

• Transcriptome analysis of A549 human pulmonary cells exposed to soluble 59Co.
• Quantitative RT-PCR to validate gene expression changes for selected genes.
• Western blotting to confirm protein level modulations.

Main Results:

• Identified 85 genes (85 Co-modulated genes) repressed or induced by cobalt exposure.
• Confirmed expression modulations for 6 genes and protein changes for 3 genes, including down-regulated TIMP2.
• Discovered 9 secreted protein candidates for cobalt toxicity biomarker research.

Conclusions:

• The study identified novel genes associated with cobalt stress, offering new hypotheses for cobalt's effects on lung epithelial cells.
• A potential biomarker for cobalt toxicity was identified, paving the way for improved diagnostics.
• These findings advance the understanding of cobalt toxicology and occupational lung disease.